Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

Zacks

Investors focused on the Consumer Staples space have likely heard of MEDIFAST INC (MED), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Consumer Staples peers, we might be able to answer that question.

MEDIFAST INC is a member of our Consumer Staples group, which includes 177 different companies and currently sits at #16 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).

The Zacks Consensus Estimate for MED's full-year earnings has moved 40.38% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, MED has returned 109.84% so far this year. At the same time, Consumer Staples stocks have lost an average of 11.88%. This shows that MEDIFAST INC is outperforming its peers so far this year.

Breaking things down more, MED is a member of the Food – Miscellaneous industry, which includes 42 individual companies and currently sits at #204 in the Zacks Industry Rank. Stocks in this group have lost about 12.02% so far this year, so MED is performing better this group in terms of year-to-date returns.

Investors with an interest in Consumer Staples stocks should continue to track MED. The stock will be looking to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply